ICON Ups China Presence and Posits Double-Standard in China Trials

ICON plc,, the global clinical-stage CRO based in Ireland, is adding to its China facilities, opening a new office in Shanghai and increasing the space of its Beijing operation. Separately, ICON said a double standard exists in China clinical trials, with different levels of quality separating trials for multinationals from those conducted for local products. More details.... Stock Symbol: (NSDQ: ICLR)     Share this with colleagues:   var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.